LAURA H. CYPHERS

In this Viewpoint, Lauren Gardner, winner of the 2022 Lasker-Bloomberg Public Service Award for creating the COVID-19 Dashboard, discusses the development of the Dashboard and the factors that contributed to its success.
Source: JAMA Online First

This Viewpoint discusses the rapid advances in molecular cell biological approaches over the past 50 years and the many avenues for future advances that have been opened, including direct applications for therapeutic and regenerative medicine.
Source: JAMA Online First

COVID-19 vaccines are considered to have prevented an estimated tens of millions of SARS-CoV-2 infections and tens of thousands of COVID-19–related deaths in the US. However, the combination of reduced vaccine effectiveness against infection in the setting of Omicron sublineages and increased vaccination coverage has resulted in an increasing number of cases among vaccinated individuals. Designing and interpreting postauthorization, observational COVID-19 vaccine effectiveness studies have also become increasingly complex due to effects of prior infection on the risk and severity of repeat infections, emergence of variants that evade vaccine-induced immunity, waning immunity, more vaccine products and dosing schedules, and heterogeneity in outcomes measured within and across studies. The proper design and interpretation of vaccine effectiveness studies have consequences for vaccine research and policy decisions and for the public’s perception and trust of vaccines.
Source: JAMA Online First

This retrospective cohort study assesses incidence of breakthrough COVID-19 and hospitalization with COVID-19 pneumonia or death among adults who received a vaccination series plus 1 booster against SARS-CoV-2.
Source: JAMA Online First

This study uses data from March 2020 to June 2022 to examine the association of the primary and booster COVID-19 vaccines with SARS-CoV-2 infection, hospitalization, and death.
Source: JAMA Online First

This study assesses the association between COVID-19 mRNA booster immunization compared with vaccination with the primary mRNA vaccination series alone and odds of hospitalization for COVID-19.
Source: JAMA Online First

This Viewpoint describes several proposals to mitigate the role of social media in medical misinformation from the ABIM Foundation’s 2022 Forum, including algorithmic adjustment, misinformation research and surveillance, and medical professional training and community engagement.
Source: JAMA Online First

This Viewpoint examines the murky legal treatment of various health-related wearable or other general wellness products for patients, physicians, and manufacturers, and recommends solutions.
Source: JAMA Online First

This Viewpoint discusses the importance of accurately categorizing and collecting race and ethnicity data, matching self-identity with race and ethnicity labels, in an effort to quantify the extent of health disparities.
Source: JAMA Online First

This Medical News feature discusses the challenges of predicting how severe flu season might be.
Source: JAMA Online First